Viewing Study NCT06525350

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:05 PM

Ignite Modification Date: 2026-01-18 @ 6:38 PM

Study NCT ID: NCT06525350

Status: NOT_YET_RECRUITING

Last Update Posted: 2024-07-29

First Post: 2024-07-18

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module